Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

$4m series A for gene testing co:

This article was originally published in Clinica

Executive Summary

Gene Security Network (GSN), a Portola Valley, California company that is developing molecular diagnostic tests using data informatics, has closed a series A financing led by Claremont Creek Ventures. Other investors include Sequoia Capital; Huntington Reproductive Centre; and Marissa Mayer, Google's vice-president of search products and user experience. GSN will use the funds to commercialise its Parental Support technology, which the company claims can test for multiple genetic diseases from a single cell. The technology is designed for use in pre-implantation genetic diagnosis during in vitro fertilisation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel